OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.5200
-0.0300 (-5.45%)
Mar 18, 2026, 4:15 PM AEST
OncoSil Medical Revenue
OncoSil Medical had revenue of 3.18M AUD in the half year ending December 31, 2025, with 395.55% growth. This brings the company's revenue in the last twelve months to 3.72M, up 95.02% year-over-year. In the fiscal year ending June 30, 2025, OncoSil Medical had annual revenue of 1.54M, down -1.92%.
Revenue (ttm)
3.72M
Revenue Growth
+95.02%
P/S Ratio
3.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.54M | -30.12K | -1.92% |
| Jun 30, 2024 | 1.57M | 97.96K | 6.68% |
| Jun 30, 2023 | 1.47M | 404.03K | 38.00% |
| Jun 30, 2022 | 1.06M | -234.94K | -18.10% |
| Jun 30, 2021 | 1.30M | -1.47M | -53.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 33.05M |
| CleanSpace Holdings | 20.66M |
| Micro-X | 16.90M |
| ImpediMed | 14.23M |
| CurveBeam AI | 12.15M |
| Control Bionics | 6.07M |
| CONNEQT Health | 5.80M |
| Atomo Diagnostics | 3.92M |
OncoSil Medical News
- 6 days ago - Oncosil Medical Ltd Extraordinary Shareholders Meeting Transcript - GuruFocus